Home Article BioScrip's home infusion revenues jump nearly 50%

BioScrip's home infusion revenues jump nearly 50%

BioScrip's home infusion revenues jump nearly 50%

Also Noted

Default Author Head Shot

By HME News Staff

Updated Fri August 8, 2014

ELMSFORD, N.Y. - BioScrip has reported revenues of $247.1 million and a net loss of $18.6 million for the second quarter of 2014. Total revenues increased by $74.8 million or 43.4% compared to the same period last year. Revenues from home infusion, specifically, increased $74.6 million or 47.8%. The growth in home infusion was driven primarily by continued strong double-digit organic growth and the acquisition of CarePoint Partners, the company stated.

Comments

To comment on this post, please log in to your account or set up an account now.